Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
1 Corporate history
3 Human applications
4 See also
6 External links
Pluristem was founded in 2001 by Shai Meretzki of the Technion, who made u...